OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+40.23%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$577M
AUM Growth
+$577M
(+18%)
Cap. Flow
+$8.44M
Cap. Flow
% of AUM
1.46%
Top 10 Holdings %
Top 10 Hldgs %
83.07%
Holding
25
New
–
Increased
8
Reduced
8
Closed
2
Top Buys
| 1 |
Pacific Biosciences
PACB
|
$5.52M |
| 2 |
AXDX
Accelerate Diagnostics
AXDX
|
$4.68M |
| 3 |
Precigen
PGEN
|
$3.85M |
| 4 |
MZOR
Mazor Robotics Ltd.
MZOR
|
$3.29M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
$2.44M |
Top Sells
| 1 |
NXTM
NxStage Medical Inc.
NXTM
|
$4.25M |
| 2 |
RGLS
Regulus Therapeutics
RGLS
|
$2.45M |
| 3 |
CMRX
Chimerix, Inc.
CMRX
|
$2.24M |
| 4 |
AGEN
Agenus
AGEN
|
$1.75M |
| 5 |
Opko Health
OPK
|
$866K |
Sector Composition
| 1 | Healthcare | 89.69% |
| 2 | Consumer Staples | 0.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXDX
1
DELISTED
Accelerate Diagnostics
AXDX
| $121M | 21.01% | 5,643,540 +217,647 | +4% | +$4.68M |
|
|
NXTM
2
DELISTED
NxStage Medical Inc.
NXTM
| $72.1M | 12.49% | 3,291,001 -194,077 | -6% | -$4.25M |
|
3
QuidelOrtho
QDEL
$1.95B
| $59.3M | 10.27% | 2,796,284 -20,000 | -0.7% | -$424K |
|
|
4
Pacific Biosciences
PACB
$393M
| $48M | 8.32% | 3,656,431 +420,270 | +13% | +$5.52M |
|
|
5
Opko Health
OPK
$1.1B
| $39.3M | 6.82% | 3,913,800 -86,200 | -2% | -$866K |
|
|
ACOR
6
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $34.9M | 6.05% | 815,838 | – | – |
|
|
MZOR
7
DELISTED
Mazor Robotics Ltd.
MZOR
| $28.6M | 4.96% | 2,816,635 +323,724 | +13% | +$3.29M |
|
|
TSRO
8
DELISTED
TESARO, Inc.
TSRO
| $28.3M | 4.9% | 540,966 +46,716 | +9% | +$2.44M |
|
|
9
Precigen
PGEN
$1.34B
| $28.1M | 4.87% | 932,585 +127,708 | +16% | +$3.85M |
|
10
Accuray
ARAY
$157M
| $19.5M | 3.37% | 2,884,305 | – | – |
|
|
VRML
11
DELISTED
Vermillion, Inc.
VRML
| $15.5M | 2.69% | 8,624,225 | – | – |
|
|
AGEN
12
Agenus
AGEN
$133M
| $13M | 2.25% | 2,865,653 -384,956 | -12% | -$1.75M |
|
|
AMRN
13
Amarin Corp
AMRN
$311M
| $12.6M | 2.18% | 6,645,793 +568,915 | +9% | +$1.08M |
|
|
WBMD
14
DELISTED
WebMD Health Corp.
WBMD
| $11.5M | 1.99% | 238,103 | – | – |
|
|
HNSN
15
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
| $10.5M | 1.81% | 4,491,820 +4 | +0% | +$9 |
|
|
BIOL
16
DELISTED
Biolase, Inc.
BIOL
| $8.86M | 1.53% | 10,529,525 +54,800 | +0.5% | +$46.1K |
|
|
TTHI
17
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
| $7.5M | 1.3% | 3,908,461 -57,561 | -1% | -$111K |
|
|
CMRX
18
DELISTED
Chimerix, Inc.
CMRX
| $6.59M | 1.14% | 736,421 -250,000 | -25% | -$2.24M |
|
|
CFRX
19
DELISTED
ContraFect Corporation
CFRX
| $5.62M | 0.97% | 1,182,032 | – | – |
|
20
Biogen
BIIB
$19.4B
| $2.37M | 0.41% | 7,723 | – | – |
|
|
YTEN
21
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
| $1.44M | 0.25% | 933,620 -24,100 | -3% | -$37.1K |
|
22
Vivani Medical
VANI
$68.1M
| $1.2M | 0.21% | 203,438 | – | – |
|
23
Alaunos Therapeutics
TCRT
$4.21M
| $1.09M | 0.19% | 131,551 -2,657 | -2% | -$22.1K |
|
|
RGLS
24
DELISTED
Regulus Therapeutics
RGLS
| – | – | -374,532 | Closed | -$2.45M |
|
|
THOR
25
DELISTED
THORATEC CORPORATION
THOR
| – | – | -5,000 | Closed | -$316K |
|